B cell reconstitution following alemtuzumab induction under a belatacept-based maintenance regimen.

Xu, He; Mehta, Aneesh K; Gao, Qimeng; Lee, Hui-Jie; Ghali, Ada; Guasch, Antonio; Kirk, Allan D

Xu, He; Mehta, Aneesh K; Gao, Qimeng; Lee, Hui-Jie; Ghali, Ada; Guasch, Antonio; Kirk, Allan D.

Afiliación

Xu H; Department of Surgery, Duke University School of Medicine, Durham, North Carolina.
Mehta AK; Emory Transplant Center, Emory University, Atlanta, Georgia.
Gao Q; Department of Surgery, Duke University School of Medicine, Durham, North Carolina.
Lee HJ; Department of Biostatistics & Bioinformatics, Duke University School of Medicine, Durham, North Carolina.
Ghali A; Emory Transplant Center, Emory University, Atlanta, Georgia.
Guasch A; Emory Transplant Center, Emory University, Atlanta, Georgia.
Kirk AD; Department of Surgery, Duke University School of Medicine, Durham, North Carolina.

Am J Transplant ; 20(3): 653-662, 2020 03.

Article en En | MEDLINE | ID: mdl-31596034

Asunto(s)

Rechazo de Injerto; Trasplante de Riñón; Abatacept/uso terapéutico; Alemtuzumab; Linfocitos B; Rechazo de Injerto/tratamiento farmacológico; Rechazo de Injerto/prevención & control; Humanos; Estudios Prospectivos

Palabras clave

B cell biology; basic (laboratory) research/science; clinical research/practice; costimulation; immunosuppression/immune modulation; immunosuppressive regimens - induction; lymphocyte biology: differentiation/maturation

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Trasplante de Riñón / Rechazo de Injerto Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Am J Transplant Asunto de la revista: TRANSPLANTE Año: 2020 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google